2016
DOI: 10.1515/hsz-2016-0131
|View full text |Cite
|
Sign up to set email alerts
|

Type II transmembrane serine proteases as potential targets for cancer therapy

Abstract: Carcinogenesis is accompanied by increased protein and activity levels of extracellular cell-surface proteases that are capable of modifying the tumor micro-environment by directly cleaving the extracellular matrix, as well as activating growth factors and proinflammatory mediators involved in proliferation and invasion of cancer cells, and recruitment of inflammatory cells. These complex processes ultimately potentiate neoplastic progression leading to local tumor cell invasion, entry into the vasculature, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 41 publications
(32 citation statements)
references
References 113 publications
0
31
0
1
Order By: Relevance
“…h uman a irway t rypsin (HAT)-like protease/ d ifferentially e xpressed in s quamous cell c arcinoma (DESC), hepsin/TMPRSS ( t rans m embrane pr otea s e/ s erine), matriptase, and corin subgroups4. Many of these TTSPs have been reported to play important roles in health and disease67891011. For example, matriptase is critical for epithelial integrity and function12.…”
mentioning
confidence: 99%
“…h uman a irway t rypsin (HAT)-like protease/ d ifferentially e xpressed in s quamous cell c arcinoma (DESC), hepsin/TMPRSS ( t rans m embrane pr otea s e/ s erine), matriptase, and corin subgroups4. Many of these TTSPs have been reported to play important roles in health and disease67891011. For example, matriptase is critical for epithelial integrity and function12.…”
mentioning
confidence: 99%
“…Thus, stably transfected TMPRSS2-overexpressing clones from a variety of prostate cancer cell lines showed increased levels of activated matriptase, which formed a 120-kDa complex with HAI-1 and corresponded with reduced levels of latent matriptase (70 kDa) and free HAI-1. These data were further corroborated by the finding that orthotopic grafts of LNCaP cells overexpressing TMPRSS2 increased both active matriptase and metastases, and that this increase is dependent upon TMPRSS2 catalytic activity [15, 65]. High-throughput screens of combinatorial libraries also identified pro-HGF as a substrate and it was confirmed that exogenous pro-HGF activated by incubation with TMPRSS2 was sufficient to activate the c-Met receptor, expressed in DU145 prostate cancer cells.…”
Section: Tmprss2mentioning
confidence: 71%
“…The dysregulation of matriptase is implicated in numerous cancers and associated with poor outcomes. For example, matriptase is shown to be overexpressed in a wide range of epithelial tumors (carcinomas) including of the breast, ovary, uterus, prostate, colon, cervix, and skin [1, 7, 15-17]. On the other hand some groups have described downregulation of matriptase mRNA in gastric and colorectal carcinomas [18, 19].…”
Section: Matriptasementioning
confidence: 99%
See 1 more Smart Citation
“…The structure of chymotrypsin in its co-crystal structure with LCMI-II has a highly-conserved backbone and binding site in comparison to cancer-associated serine proteases (32). Specifically, the type II transmembrane serine proteases matriptase, hepsin, TMPRSS2, and TMPRSS4 have been found to be overexpressed in many cancers, predominantly studied in prostate, breast, and ovarian cancers (33). Binding to these transmembrane proteins has the potential to trigger endocytosis and internalization of peptide-dye and peptide-drug conjugates that lead to payload delivery.…”
Section: Discussionmentioning
confidence: 99%